BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7268693)

  • 1. Responses of rabbit platelets to adrenaline induced by other agonists.
    Hallam TJ; Scrutton MC; Wallis RB
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):413-24. PubMed ID: 7268693
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation induced by a stable analogue of endoperoxides (U46619).
    Zatta A; Prosdocimi M
    Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
    [No Abstract]   [Full Text] [Related]  

  • 4. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.
    Mayo JR; Navran SS; Huzoor-Akbar ; Miller DD; Feller DR
    Biochem Pharmacol; 1981 Aug; 30(16):2237-41. PubMed ID: 7188564
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro.
    Lumley P; Humphrey PP
    J Pharmacol Methods; 1981 Sep; 6(2):153-66. PubMed ID: 7289632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate potentiates the action of platelet agonists.
    Huang EM; McGowan EB; Detwiler TC
    Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.
    Nakano T; Hanasaki K; Arita H
    Thromb Res; 1989 Oct; 56(2):299-306. PubMed ID: 2617470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of heat on platelet biochemistry, structure, and function.
    Rao GH; Smith CM; Escolar G; White JG
    J Lab Clin Med; 1993 Oct; 122(4):455-64. PubMed ID: 8228561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.